This is a single center, open-label, monocentric, multiple IV dose, phase I study to investigate the penetration of rifabutin into the lung after multiple intravenous administrations of BV100 (rifabutin for infusion) in healthy participants.
Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100